v3.26.1
STOCKHOLDERS EQUITY (DEFICIT) (Tables)
3 Months Ended
Mar. 31, 2026
STOCKHOLDERS EQUITY (DEFICIT)  
Summary of stock issued for services

Quantity of Preferred Stock Series B shares issued

 

 

15,000

 

Conversion ratio of Preferred Stock Series B into Common Stock

 

 

50

 

Equivalent quantity of common shares

 

 

750,000

 

Cash offering price of common shares

 

$1.00

 

Value of Preferred Stock Series B shares issued

 

$750,000

 

Quantity of Preferred Stock Series B shares issued

 

 

10,000

 

Conversion ratio of Preferred Stock Series B into Common Stock

 

 

50

 

Equivalent quantity of common shares

 

 

500,000

 

Cash offering price of common shares

 

$1.00

 

Value of Preferred Stock Series B shares issued

 

$500,000

 

Quantity of Preferred Stock Series B shares issued

 

 

50,000

 

Conversion ratio of Preferred Stock Series B into Common Stock

 

 

50

 

Equivalent quantity of common shares

 

 

2,500,000

 

Cash offering price of common shares

 

$1.00

 

Value of Preferred Stock Series B shares issued

 

$2,500,000

 

Summary of warrants

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

 

 

 

 

Number

 

 

Average

 

 

Contractual

 

 

Aggregate

 

 

 

Of

 

 

Exercise

 

 

Term

 

 

Intrinsic

 

 

 

Warrants

 

 

Price

 

 

(In Years)

 

 

Value

 

Outstanding and exercisable as of January 1, 2024

 

 

1,000,000

 

 

$3.50

 

 

 

1.6

 

 

$2,500,000

 

Issued during 2024

 

 

1,270,000

 

 

$3.50

 

 

 

2.2

 

 

 

n/a

 

Outstanding and exercisable as of December 31, 2024

 

 

2,270,000

 

 

$3.50

 

 

 

2.1

 

 

$3,382,300

 

Issued during 2025

 

 

3,370,000

 

 

$1.75

 

 

 

5.1

 

 

 

n/a

 

Outstanding and exercisable as of January 1, 2025

 

 

5,640,000

 

 

$2.45

 

 

 

3.3

 

 

$20,954,615

 

Issued during 2026

 

 

350,000

 

 

$0.01

 

 

 

-

 

 

 

n/a

 

Outstanding and exercisable as of March 31, 2026

 

 

5,990,000

 

 

$2.45

 

 

 

3.0

 

 

$23,361,000

 

Summary of warrants valuation assumptions

Expected term (in years)

 

 

2.7

 

Volatility

 

 

52%

Dividends

 

None

 

Risk-free interest rate

 

 

4.6%